2 more firms seek FDA nod on COVID-19 vaccines
Two new applications—one for monovalent and the other for bivalent vaccines—are pending with the Food and Drug Administration (FDA) for their commercial use against COVID-19, according to Director General Samuel Zacate. The FDA chief, however, did not elaborate. So far, only Pfizer’s bivalent vaccine under the brand name Comirnaty Original/Omicron BA.4-5 was given the certificate […]
The post 2 more firms seek FDA nod on COVID-19 vaccines appeared first on Inquirer News.
Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.